Galera to participate in the h.c. wainwright 24th annual global investment conference

Malvern, pa., sept. 06, 2022 (globe newswire) -- galera therapeutics, inc. (nasdaq: grtx), a clinical-stage biopharmaceutical company focused on developing and commercializing a pipeline of novel, proprietary therapeutics that have the potential to transform radiotherapy in cancer, today announced that mel sorensen, m.d., president and chief executive officer, will participate in a fireside chat at the h.c. wainwright 24th annual global investment conference on monday, september 12, 2022 at 4:30 p.m. e.t.
GRTX Ratings Summary
GRTX Quant Ranking